DeRUCCI - Public Comps and Valuation Multiples

DeRUCCI Overview

About DeRUCCI

De Rucci Healthy Sleep Co Ltd specializes in the research and development, production and sales of a complete set of healthy sleep systems.

Founded

2007

HQ

Employees

n/a

Website

derucci.com

Sectors

Financials

LTM Revenue $810M

LTM EBITDA $169M

EV

$1.4B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

DeRUCCI Financials

As of January 2026, DeRUCCI reported last 12-month revenue of $810M and EBITDA of $169M.

In the same period, DeRUCCI generated $412M in LTM gross profit and $102M in net income.

See DeRUCCI valuation multiples based on analyst estimates

DeRUCCI P&L

In the most recent fiscal year, DeRUCCI reported revenue of $809M and EBITDA of $169M.

DeRUCCI expects next 12-month revenue of XXX and NTM EBITDA of XXX

See DeRUCCI valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Revenue	$810M	XXX	$809M	XXX	XXX	XXX
Gross Profit	$412M	XXX	$405M	XXX	XXX	XXX
Gross Margin	51%	XXX	50%	XXX	XXX	XXX
EBITDA	$169M	XXX	$169M	XXX	XXX	XXX
EBITDA Margin	21%	XXX	21%	XXX	XXX	XXX
EBIT	$122M	XXX	$126M	XXX	XXX	XXX
EBIT Margin	15%	XXX	16%	XXX	XXX	XXX
Net Profit	$102M	XXX	$111M	XXX	XXX	XXX
Net Margin	13%	XXX	14%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for DeRUCCI including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $810M. EBITDA for the last twelve months was $169M. In the most recent fiscal year, DeRUCCI achieved $809M in revenue and $169M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2026)	Next Fiscal Year (2027)	Two Years Forward (2028)
Total Revenue	$810M	Analyst estimates available to subscribers	$809M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$412M	Analyst estimates available to subscribers	$405M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	50.8% gross margin	Analyst estimates available to subscribers	50.1% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$169M	Analyst estimates available to subscribers	$169M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	20.8% EBITDA margin	Analyst estimates available to subscribers	20.9% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$122M	Analyst estimates available to subscribers	$126M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	15.0% EBIT margin	Analyst estimates available to subscribers	15.6% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$102M	Analyst estimates available to subscribers	$111M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	12.6% net profit margin	Analyst estimates available to subscribers	13.7% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for DeRUCCI

This financial data table provides comprehensive performance metrics for DeRUCCI, a company based in China. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

DeRUCCI generated $810M in revenue over the last twelve months.
The company achieved $169M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $412M.
Net income over the last twelve months reached $102M.

Fiscal Year Performance

In the most recent fiscal year, DeRUCCI reported $809M in total revenue.
Fiscal year EBITDA was $169M.
The company maintained a gross profit margin of 50.1% in the most recent fiscal year.
EBITDA margin for the fiscal year was 20.9%.
Net profit margin reached 13.7% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for DeRUCCI. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

DeRUCCI Stock Performance

DeRUCCI has current market cap of CNY 11.7B (or $1.7B), and EV of CNY 9.7B (or $1.4B).

Market Cap Evolution

DeRUCCI Stock Data

As of February 25, 2026, DeRUCCI's stock price is CNY 27 (or $4).

See DeRUCCI trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$1.4B	$1.7B	XXX	XXX	XXX	XXX	$0.23

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

DeRUCCI Valuation Multiples

DeRUCCI's trades at 1.7x EV/Revenue multiple, and 8.3x EV/EBITDA.

See valuation multiples for DeRUCCI and 15K+ public comps

DeRUCCI Financial Valuation Multiples

As of February 25, 2026, DeRUCCI has market cap of $1.7B and EV of $1.4B.

Equity research analysts estimate DeRUCCI's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

DeRUCCI has a P/E ratio of 16.7x.

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Market cap (current)	$1.7B	XXX	$1.7B	XXX	XXX	XXX
EV (current)	$1.4B	XXX	$1.4B	XXX	XXX	XXX
EV/Revenue	1.7x	XXX	1.7x	XXX	XXX	XXX
EV/EBITDA	8.3x	XXX	8.3x	XXX	XXX	XXX
EV/EBIT	11.5x	XXX	11.5x	XXX	XXX	XXX
EV/Gross Profit	3.4x	XXX	n/a	XXX	XXX	XXX
P/E	16.7x	XXX	16.7x	XXX	XXX	XXX
EV/FCF	n/a	XXX	13.6x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get DeRUCCI Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

DeRUCCI Margins & Growth Rates

DeRUCCI's last 12 month revenue growth is 6%

DeRUCCI's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.

DeRUCCI's rule of 40 is 28% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

DeRUCCI's rule of X is 36% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for DeRUCCI and other 15K+ public comps

DeRUCCI Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2026	FY 2027	FY 2028
Revenue Growth	6%	XXX	8%	XXX	XXX	XXX
EBITDA Margin	21%	XXX	21%	XXX	XXX	XXX
EBITDA Growth	7%	XXX	-1%	XXX	XXX	XXX
Rule of 40	28%	XXX	27%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	36%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	n/a	XXX	XXX	XXX
Opex per Employee	XXX	XXX	n/a	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	18%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	4%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	35%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial